Showing results (131-140 of 373) with videos related to

Sort By:
Pageof 38
RMD Open|February 20, 2020
Treat-to-target in PsA: methods and necessityEmma Dures, Sasha Shepperd, Sandeep Mukherjee, et al.
The Journal of Rheumatology. Supplement|June 2, 2021
GRAPPA Treatment Recommendations: An Update From the 2020 GRAPPA Annual MeetingLaura C Coates, Nadia Corp, Danielle A van der Windt, et al.
Clinical Trials (London, England)|August 25, 2021
Simulation-based design of pragmatic trials in psoriatic arthritis using propensity scoresSarah M Weinstein, Laura C Coates, Philip S Helliwell, et al.
The Journal of Rheumatology. Supplement|June 2, 2021
Instruments Measuring Physical Function for Psoriatic Arthritis Endorsed at GRAPPA 2020 Annual Meeting: Updates of the GRAPPA-OMERACT Working GroupYing Ying Leung, Ana-Maria Orbai, William Tillett, et al.
The Journal of Rheumatology|May 3, 2017
Defining Outcome Measures for Psoriatic Arthritis: A Report from the GRAPPA-OMERACT Working GroupAlexis Ogdie, Maarten de Wit, Kristina Callis Duffin, et al.
The Journal of Rheumatology|March 2, 2021
Instruments Measuring Physical Function for Psoriatic Arthritis Endorsed at GRAPPA 2020 Annual Meeting: Updates of the GRAPPA-OMERACT Working GroupYing Ying Leung, Ana-Maria Orbai, William Tillett, et al.
Rheumatology (Oxford, England)|September 12, 2018
Risk of type 2 diabetes and cardiovascular disease in an incident cohort of people with psoriatic arthritis: a population-based cohort studyRachel Charlton, Amelia Green, Gavin Shaddick, et al.
The Journal of Rheumatology|November 18, 2011
The ClASsification for Psoriatic ARthritis (CASPAR) criteria--a retrospective feasibility, sensitivity, and specificity studyWilliam Tillett, Luisa Costa, Deepak Jadon, et al.
Pageof 38